The Efficacy of Canagliflozin on Type 2 Diabetic Nephropathy in Male Rats
Background: Sodium-glucose Cotransporter-2 inhibitors [SGLT2Is] are new antidiabetic group. Canagliflozin is the first member in this drug class approved for management of patient with type 2 diabetes (T2DM), that affects reabsorption of glucose from kidney, but its impact on kidney structure and fu...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
South Valley University, Faculty of Medicine
2023-07-01
|
| Series: | SVU - International Journal of Medical Sciences |
| Subjects: | |
| Online Access: | https://svuijm.journals.ekb.eg/article_318205.html |